IMMUNOCHEMISTRY OF CAPSULAR TYPE POLYSACCHARIDE AND VIRULENCE PROPERTIES OF TYPE-VI STREPTOCOCCUS-AGALACTIAE (GROUP-B STREPTOCOCCI)

被引:43
作者
VONHUNOLSTEIN, C
DASCENZI, S
WAGNER, B
JELINKOVA, J
ALFARONE, G
RECCHIA, S
WAGNER, M
OREFICI, G
机构
[1] IST SUPER SANITA, BACTERIOL & MED MYCOL LAB, VIALE REGINA ELENA 299, I-00161 ROME, ITALY
[2] FRIEDRICH SCHILLER UNIV, INST EXPTL MICROBIOL, O-6900 JENA, GERMANY
[3] NATL PUBL HLTH INST, CS-10042 PRAGUE 10, CZECHOSLOVAKIA
关键词
D O I
10.1128/IAI.61.4.1272-1280.1993
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immunochemistry of capsular type polysaccharide and virulence characteristics of group B streptococci (GBS), type VI, were studied. By high-pressure anion-exchange chromatography and pulsed amperometric detection, as well as by C-13 nuclear magnetic resonance analysis, both extracellular and cell-bound polysaccharides were found to contain glucose, galactose, and N-acetylneuraminic acid in the molar ratio of 2:2:1, respectively. At variance with all other GBS serotypes described to date (Ia, Ib, II, III, IV, and V), no N-acetylglucosamine was present, whatever the source of the material (secreted or cell bound; reference or clinical isolate). Sialic acid was probably involved in the immunodeterminant structure of this new serotype since cleavage of this sugar from the polysaccharide gave rise to an antigen which reacted very weakly with type VI antiserum and to a precipitation line in immunodiffusion with no identity with the native type VI polysaccharide. By using type VI antiserum and the protein A-gold technique, a large capsule was observed in the type VI GBS reference strain by electron microscopy. All type VI strains examined were lethal for CD-1 mice, the 50% lethal dose after intraperitoneal challenge ranging from 1.0 (+/- 0.9, standard deviation) x 10(5) to 2.5 (+/- 1.5, standard deviation) x 10(5) CFU per mouse. A rabbit antiserum against capsular type polysaccharide exhibited both protective activity for mice injected intraperitoneally with type VI reference strain or with clinical isolates and opsonic activity in a phagocytosis assay.
引用
收藏
页码:1272 / 1280
页数:9
相关论文
共 53 条
[1]   GROUP-B STREPTOCOCCAL INFECTIONS - PERINATAL IMPACT AND PREVENTION METHODS [J].
BAKER, CJ ;
EDWARDS, MS .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1988, 549 :193-202
[2]   MOUSE PROTECTION TEST FOR GROUP-B STREPTOCOCCUS TYPE-III [J].
BALTIMORE, RS ;
KASPER, DL ;
VECCHITTO, J .
JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (01) :81-88
[3]  
BALTIMORE RS, 1977, J IMMUNOL, V118, P673
[4]   STRUCTURAL AND CONFORMATIONAL-ANALYSIS OF SIALYLOLIGOSACCHARIDES USING C-13 NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY [J].
BERMAN, E .
BIOCHEMISTRY, 1984, 23 (16) :3754-3759
[5]  
BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926
[6]   C-13 NUCLEAR MAGNETIC-RESONANCE DATA FOR OLIGOSACCHARIDES [J].
BOCK, K ;
PEDERSEN, C ;
PEDERSEN, H .
ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY, 1984, 42 :193-225
[7]  
BROSSMER R, 1992, J BIOL CHEM, V267, P8752
[8]  
CLEAT PH, 1981, BRIT J EXP PATHOL, V62, P393
[9]  
DASCENZI S, 1992, ZBL BAKT S, V22, P458
[10]  
DIFABIO JL, 1989, CAN J CHEM, V67, P877